MAPT and Alzheimer disease: The consequence of the brain accumulation of Aβ and tau can be detected by analyzing the levels of Aβ42 peptide (the most neurotoxic isoform of Aβ) and total tau (t-tau) protein in the cerebrospinal fluid (CSF) of AD patients.